Anti-TRAP1 抗体 [TRAP1-6]
Anti-TRAP1 antibody [TRAP1-6]
Be the first to review this product! Submit a review
|
(15 Publications)
Mouse Monoclonal TRAP1 antibody. Suitable for IP, WB, IHC-P, ICC/IF and reacts with Human, Mouse samples. Cited in 15 publications. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human TRAP1.
別名を表示する
HSP75, HSPC5, TRAP1, HSP 75, Heat shock protein family C member 5, TNFR-associated protein 1, Tumor necrosis factor type 1 receptor-associated protein, TRAP-1
- WB
Unknown
Western blot - Anti-TRAP1 antibody [TRAP1-6] (AB2721)
The band observed at 76 kDa could potentially be a cleaved form of TRAP1 due to the presence of a 59 amino acid transit peptide.
All lanes:
Western blot - Anti-TRAP1 antibody [TRAP1-6] (ab2721) at 1 µg/mL
Lane 1:
Human brain tissue lysate - total protein (ab29466) at 10 µg
Lane 2:
HEK293 (Human embryonic kidney cell line) Whole Cell Lysate at 10 µg
Lane 3:
HepG2 (Human hepatocellular liver carcinoma cell line) Whole Cell Lysate at 10 µg
Secondary
All lanes:
Goat polyclonal Secondary Antibody to Mouse IgG - H&L (HRP), pre-adsorbed at 1/5000 dilution
Predicted band size: 80 kDa
Observed band size: 40 kDa,76 kDa
true
Exposure time: 16min
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-TRAP1 antibody [TRAP1-6] (AB2721)
ab2721 staining TRAP1 in NCI-H460 cells by Immunocytochemistry/Immunofluorescence. Cells were grown on chamber slides and fixed with formaldehyde. Cells were probed without (right) or primary antibody (left) at a dilution of 1 : 200 overnight at 4 C, washed with PBS and incubated with a DyLight-488 conjugated secondary antibody. Green - TRAP1, Red (phalloidin) - F-actin, Blue (DAPI) - nuclei. Images were taken at 60X magnification.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-TRAP1 antibody [TRAP1-6] (AB2721)
ICC/IF image of ab2721 stained HepG2 cells. The cells were 4% PFA fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab2721, 5µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-mouse IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TRAP1 antibody [TRAP1-6] (AB2721)
Immunohistochemistry was performed on normal biopsies of deparaffinized Human liver tissue. To expose target proteins heat induced antigen retrieval was performed using 10mM sodium citrate (pH6.0) buffer and microwaved for 8-15 minutes. Following antigen retrieval tissues were blocked in 3% BSA-PBS for 30 minutes at room temperature and probed with a TRAP1 monoclonal antibody (ab2721) at a dilution of 1 : 20 or without primary antibody (negative control) overnight at 4°C in a humidified chamber. Tissues were washed with PBST and endogenous peroxidase activity was quenched with a peroxidase suppressor. Detection was performed using a biotin-conjugated secondary antibody and SA-HRP followed by colorimetric detection using DAB. Tissues were counterstained with hematoxylin and prepped for mounting.
- IP
Unknown
Immunoprecipitation - Anti-TRAP1 antibody [TRAP1-6] (AB2721)
Immunoprecipitation of TRAP1 using ab2721 visualized by Coomassie Blue staining.
All lanes:
Immunoprecipitation - Anti-TRAP1 antibody [TRAP1-6] (ab2721)
Predicted band size: 80 kDa
false
- IP
Unknown
Immunoprecipitation - Anti-TRAP1 antibody [TRAP1-6] (AB2721)
TRAP1 was immunoprecipitated using 0.5mg HepG2 whole cell extract, 5μg of Mouse monoclonal to TRAP1 (ab2721)and 50μl of protein G magnetic beads (lane 1). The antibody was incubated with the Protein G beads for 10min under agitation. No antibody was added to the control (lane 2). HepG2 whole cell extract diluted in RIPA buffer was added to each sample and incubated for 10min under agitation. Proteins were eluted by addition of 40μl SDS loading buffer and incubated for 10min at 70oC; 10μl of each sample was separated on a SDS PAGE gel, transferred to a nitrocellulose membrane, blocked with 5% BSA and probed with ab2721. Secondary : Goat polyclonal to mouse IgG light chain specific (HRP) at 1/5000 dilution.
Bands : 75kDa : TRAP1
All lanes:
Immunoprecipitation - Anti-TRAP1 antibody [TRAP1-6] (ab2721)
Predicted band size: 80 kDa
false
- WB
Unknown
Western blot - Anti-TRAP1 antibody [TRAP1-6] (AB2721)
All lanes:
Western blot - Anti-TRAP1 antibody [TRAP1-6] (ab2721) at 1/2000 dilution
Lane 1:
HeLa whole cell lysate at 30 µg
Lane 2:
Hep G2 whole cell lysate at 30 µg
Lane 3:
HEK-293 whole cell lysate at 30 µg
Lane 4:
K-562 whole cell lysate at 30 µg
Secondary
All lanes:
Goat anti-Mouse IgG (H+L) Superclonal™ Recombinant Secondary Antibody, HRP at 1/40000 dilution
Predicted band size: 80 kDa
false
Reactivity data
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This mitochondrial chaperone plays an important role in maintaining protein homeostasis within the cellular environment. It forms part of a complex with heat shock proteins coordinating cellular defense mechanisms against stress. TRAP1 interacts with other chaperones to stabilize proteins and assist in mitochondrial quality control. Its activities aid in reducing oxidative stress managing apoptosis and regulating mitochondrial dynamics. Through these functions TRAP1 supports cellular survival and metabolic adaptation under conditions of stress.
Pathways
TRAP1 is involved in the regulation of the mitochondrial apoptosis pathway and the oxidative stress response pathway. It interacts with proteins like cytochrome c and inhibitors of apoptosis proteins (IAPs) influencing the release of pro-apoptotic factors and modulation of survival signals. By modulating these pathways TRAP1 affects cellular energy production and stress responses impacting both cellular health and disease states.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (15)
Recent publications for all applications. Explore the full list and refine your search
Heliyon 9:e21412 PubMed37920489
2023
Applications
Unspecified application
Species
Unspecified reactive species
Bioengineered 13:2285-2295 PubMed35034537
2022
Applications
Unspecified application
Species
Unspecified reactive species
Communications biology 2:258 PubMed31312727
2019
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 292:16697-16708 PubMed28848050
2017
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 14:2473-82 PubMed27484039
2016
Applications
WB
Species
Unspecified reactive species
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 30:1712-23 PubMed26722004
2016
Applications
Unspecified application
Species
Unspecified reactive species
Journal of molecular neuroscience : MN 55:62-68 PubMed25189320
2014
Applications
Unspecified application
Species
Unspecified reactive species
The EMBO journal 33:282-95 PubMed24446486
2014
Applications
Unspecified application
Species
Unspecified reactive species
Kidney international 85:1310-7 PubMed24152966
2013
Applications
Unspecified application
Species
Human
The Journal of cell biology 200:163-72 PubMed23319602
2013
Applications
ICC/IF
Species
Human
Abcam product promise
関連製品
Alternative Product
Primary Antibodies
AB151239
Anti-TRAP1 antibody
primary-antibodies
trap1-antibody-ab151239
0
(0 reviews)
Alternative Product
Primary Antibodies
AB223379
Anti-TRAP1 antibody
primary-antibodies
trap1-antibody-ab223379
0
(0 reviews)
Alternative Product
Primary Antibodies
AB109323
Anti-TRAP1 antibody [EPR5381]
primary-antibodies
trap1-antibody-epr5381-ab109323
0
(0 reviews)
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com